Noradrenergic and dopaminergic mechanisms in Gilles de la Tourette syndrome.
D001921:Brain / Q000378:metabolism; D003891:Desipramine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism*; D005879:Tourette Syndrome / Q000188:drug therapy / Q000503:physiopathology*
D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine